Pharmaceutical Care of a Patient with HBV Infection after Second Renal Transplantation

doi:10.19803/j.1672-8629.2021.07.20

Abstract

Abstract: Objective To explore pharmaceutical care methods for patients with hepatitis B virus (HBV) infection after second renal transplantation. Methods Clinical pharmacist provided individualized pharmaceutical care for a patient with HBV infection after second renal transplantation, analyzed the abnormal indexes during treatment, and offered recommendations about pharmacy. Results Urine protein and urine microalbumin disappeared, hepatitis B virus-related liver damage was improved, and the tacrolimus concentration was controlled to reach the standard. Conclusion Clinical pharmacists need to offer individualized pharmaceutical care for patients with hepatitis B virus infection after renal transplantation.

Key words: renal transplantation, HBV-infection, pharmaceutical care

CLC Number:

R975.5

SUN Shaowei, LIN Tingting, WEI Chuanmei, LYU Wenwen, SONG Zheng. Pharmaceutical Care of a Patient with HBV Infection after Second Renal Transplantation[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 689-692.

References

[1] Yi B, Wang S.The significance of three indexes of renal function in judging the short-term efficacy of kidney transplantation[J].Practical Preventive Medicine(实用预防医学), 2007, 14(3): 842-844.
[2] He JF, Dong M, Tong AH, et al.Clinical significance of dynamic monitoring of serum liver and kidney function indicators in recipients after kidney transplantation[J]. Medical Journal of the Chinese People's Armed Police Force(武警医学), 2013, 24(10): 884-886.
[3] Zuo FJ, Wang LM, Feng XF, et al.Effects of glucocorticoid removal on urinary microproteins in renal transplant recipients[J]. Chinese Journal of Tissue Engineering(中国组织工程研究), 2014, 18(36): 5770-5775.
[4] Liu SF, Yang SL.Clinical analysis and follow-up management of liver function impairment after kidney transplantation in patients with Hepatitis B virus[J]. General Practice Nursing(全科护理), 2015, 13(17): 1635-1637.
[5] MomperJD, Ridenour TA, Schonder KS, et a1. The impact of conversion from prograf to genetic tacrolimus in liverand kidney transplant recipients with stable graft function[J]. Am J Transplant, 2011, 11(9): 1861-1867.
[6] Zhou JX, Liu D, Wu JQ, et al.Follow-up monitoring and management of HBsAg positive patients after kidney transplantation[J].Guangdong Medical Science(广东医学), 2011, 32(4): 477-479.
[7] Han S, Zhu YH, Wang LM, et al.Major factors influencing the clinical outcome of renal retransplantation[J]. Journal of Clinical Urology(临床泌尿外科杂志), 2008, 23(1): 4-6.
[8] Organ Transplantation Branch of Chinese Medical Association, Organ Transplant Doctors Branch of Chinese Medical Doctor Association.Chinese guidelines for immunosuppressive therapy for kidney transplant recipients (2016 edition)[J]. Organ Transplantation(器官移植), 2016, 7(5): 1-5.
[9] Zhang HX, Liu XD, Wang CY.Observation on the curative effect of Rhubarb Shizhiworm Pill combined with entecavir in the treatment of chronic hepatitis B cirrhosis[J]. Chinese Journal of Integrative Medicine Digestion(中国中西医结合消化杂志), 2016, 24(8): 575-577.
[10] Guo WM, Ye J, Fu GH, et al.Effect observation of rhubarb stellate pill in the treatment of hepatitis b[J]. Heilongjiang Medicine(黑龙江医药), 2000, 13(3): 181.
[11] Steiner R, Chanchaimira T, Leyden S.Proteinuria in“normal” cadaver kidney donors[J]. Transplantation, 2002, 74(12): 1788-1803.
[12] Huang T, Li SJ, Gao Y, et al.Changes of homocysteine, renal function and blood lipid in patients after renal transplantation and their correlation analysis[J]. Advances in Modern Biomedicine(现代生物医学进展), 2017, 17(30): 5908-5920.
[13] Zhou Q.Cause analysis of proteinuria after renal transplantation and its influence on graft survival[D]. Shanghai: Fudan University Huashan Hospital, 2009.
[14] Zhou JX, Liu D, Wu JQ, et al.Follow-up monitoring and manag-ement of HBsAg positive patients after kidney transplantation[J].Guangdong Medical Science(广东医学), 2011, 32(4): 477-479.
[15] Wang SX, Gao G, Sheng CL.Clinical observation of liver damage in renal transplant patients with hepatitis virus infection[J]. Journal of Clinical Hepatobiliary Disease(临床肝胆病杂志), 2004, 20(1): 19-20.
[16] Mao XM, Wang C, Zhang Y.Effect of abnormal liver function on the blood concentration of tacrolimus after liver transplantation[J]. Inner Mongolia Chinese Medicine(内蒙古中医药), 2013, 32(16): 3-5.
[17] Wu X, Cai L, Shi SP, et al.Effect of pentacyl capsules on blood concentration of tacrolimus in renal transplant patients[J]. Chinese Pharmacy(中国药房), 2013, 24(43): 4095-4097.
[18] Yang H, Hu XP, Yang XY,et al.Pharmacokinetic interaction between glucocorticoids and tacrolimusafterrenal transplantation[J]. Journal of Chinese Pharmaceutical Sciences(中国药学(英文版)), 2019, 28(4): 257-263.
[19] Xiong Q, Xu Y.Effect of rhubarb combined with tacrolimus on blood drug concentration in patients with nephrotic syndrome[J]. Jiangxi Chinese Medicine(江西中医药), 2016, 47(400): 49.
[20] Pang XY Shen JF. A case of increased blood concentration of tacrolimus induced by berberine hydrochloride[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2012, 9(10): 640.